(Updates in Hypertension and Cardiovascular Protection) 1st ed. 2019 Edition
by Reuven Zimlichman (Editor), Stevo Julius (Editor), Giuseppe Mancia (Editor)
This book sheds new light on the
management of patients with borderline cardiovascular risk factors in
order to prevent their progression to end organ damage. The book
stimulates discussion of this poorly understood condition and lays the
groundwork for developing recommendations and guidelines.
While
the diagnostic and therapeutic approach to full-blown diabetes,
hypertension, dyslipidemia and obesity is well defined, there is still a
lack of clear understanding and guidelines as far as patients with
borderline conditions – especially when multiple – are concerned.
Moreover, end-organ damage depends on several factors, including genetic
factors, making it difficult to predict its extent. As such, the
gradual transition from a healthy subject to one with functional
hemodynamic changes, and then one with structurally asymptomatic changes
and lastly to overt disease needs further investigation.
In order
to address these knowledge gaps, the book covers a broad variety of
topics, making it a valuable tool for identifying which asymptomatic
subjects could profit from being appropriately screened and at what
stage. Furthermore it offers insights into better treating these
patients to prevent their progression to overt disease. The book appeals
to cardiologists, primary care physicians and all those healthcare
professional looking to optimize the management of these complex and
often undiagnosed cases.
